Overview

Molecule runs a decentralized biotech marketplace that connects scientists and researchers with investors to fund and advance novel research and intellectual property. Its platform tokenizes IP into IP-NFTs and enables the creation of Bio-DAOs, letting researchers raise funds and investors gain fractional ownership in early-stage biotech assets. The process works by packaging research projects as IP-NFTs and organizing collaborative governance through Bio-DAOs, with trades and funding occurring on a decentralized platform that charges transaction or onboarding fees. Molecule differentiates itself by embracing the DeSci trend, using tokenization and fractional ownership to streamline asset transfer, fundraising, and collaboration across the life sciences, rather than relying on traditional venture-backed rounds. The goal is to accelerate innovation in drug development and other scientific research by providing new funding avenues and a more open, efficient market for research assets.